Ibutilide

59 interactions 4 explained in plain English

Also sold as: Corvert

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Moxifloxacin Ophthalmic Disopyramide Fostemsavir Deutetrabenazine Olodaterol Oral Inhalation Oxaliplatin Injection

59 Major

All (59) Major (59)

Major

Ibutilide Amitriptyline Elavil Explained An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Sertraline Explained An increased risk of QT interval prolongation Details Ibutilide Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Ibutilide Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Ibutilide Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Ibutilide Arsenic Trioxide Trisenox Cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Ibutilide Arsenic Trioxide Injection Trisenox Cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Ibutilide Azithromycin AzaSite An increased risk of cardiotoxicity (QT interval prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Alfuzosin UroXatral An increased risk of QT interval prolongation Details Ibutilide Anagrelide Agrylin Increased risk of QT interval prolongation Details Ibutilide Bedaquiline Sirturo Increased risk of QT interval prolongation Details Ibutilide Chloroquine Aralen® Cardiotoxicity (QT interval prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Dasatinib Phyrago An increased risk of QT interval prolongation Details Ibutilide Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Ibutilide Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Ibutilide Disopyramide Norpace An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Dofetilide Tikosyn An increased risk of QT interval prolongation Details Ibutilide Dolasetron Anzemet Cardiotoxicity (QT prolongation, torsade de pointes, cardiac arrest) Details Ibutilide Dolasetron Injection Anzemet Cardiotoxicity (QT prolongation, torsade de pointes, cardiac arrest) Details Ibutilide Encorafenib Braftovi Increased risk of QT interval prolongation Details Ibutilide Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Ibutilide Flecainide Tambocor® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Foscarnet Injection Foscavir An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Fostemsavir Rukobia Increased risk of torsade de pointes Details Ibutilide Gatifloxacin Ophthalmic Zymar® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Gemifloxacin Factive An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Glasdegib Daurismo Increased risk of QT interval prolongation Details Ibutilide Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Ibutilide Granisetron Transdermal Patch Sancuso An increased risk of QT interval prolongation Details Ibutilide Granisetron Injection Granisol An increased risk of QT interval prolongation Details Ibutilide Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Ibutilide Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Ibutilide Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Ibutilide Isradipine DynaCirc® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Ivabradine Corlanor Increased risk of QT prolongation Details Ibutilide Ketoconazole Topical Extina® Foam Increased risk of QT interval prolongation and an increased risk of torsades de pointes and cardiac arrest Details Ibutilide Lacosamide Injection Motpoly An increased risk of AV block, bradycardia, and ventricular tachyarrhythmia Details Ibutilide Lefamulin Xenleta Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.